Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
Gianluca Dini(University of Perugia), Alberto Verrottı(University of Perugia), Eleonora Tulli(University of Perugia), Giuseppe Di Cara(University of Perugia), Pasquale Striano(Istituto Giannina Gaslini), Giovanni Battista Dell’Isola(Saint Camillus International University of Health and Medical Sciences), Elisabetta Mencaroni(University of Perugia)
Cited by 17
Related Papers
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Autism Spectrum Disorders and the Gut Microbiota
|Nutrients|2019|479
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
|Frontiers in Neurology|2021|260
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|248
Defining the phenotypic spectrum of <i>SLC6A1</i> mutations
|Epilepsia|2018|151